These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 10442282

  • 1. [A case of multiple endocrine neoplasia type 2A (MEN2A) with a mutation in the RET gene].
    Ishizu K, Shiraishi K, Kawamura H, Naito K, Takahashi T, Yoshimura K, Tangoku A, Shirahama S.
    Hinyokika Kiyo; 1999 Jun; 45(6):407-10. PubMed ID: 10442282
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
    Sansó G, Domené HM, Iorcansky S, Barontini M.
    Medicina (B Aires); 1998 Jun; 58(2):179-84. PubMed ID: 9706252
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Catecholamine crisis as a first manifestation of familial bilateral pheochromocytoma caused by RET proto-oncogene mutation in codon C 634R.
    Zwolak A, Rudzki G, Świrska J, Dudzińska M, Daniluk J, Tarach J.
    Endokrynol Pol; 2015 Jun; 66(5):462-8. PubMed ID: 26457501
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Adrenal and extra-adrenal pheochromocytomas in a family with germline RET V804L mutation.
    Nilsson O, Tisell LE, Jansson S, Ahlman H, Gimm O, Eng C.
    JAMA; 1999 May 05; 281(17):1587-8. PubMed ID: 10235148
    [No Abstract] [Full Text] [Related]

  • 10. Composite phaeochromocytoma-ganglioneuroblastoma in a patient with multiple endocrine neoplasia type IIA.
    Matias-Guiu X, Garrastazu MT.
    Histopathology; 1998 Mar 05; 32(3):281-2. PubMed ID: 9568520
    [No Abstract] [Full Text] [Related]

  • 11. Multiple endocrine neoplasia type iia: report of a family with a study of three generations in qatar.
    Zirie M, Mohammed I, El-Emadi M, Haider A.
    Endocr Pract; 2001 Mar 05; 7(1):19-27. PubMed ID: 11250764
    [Abstract] [Full Text] [Related]

  • 12. Molecular and biochemical screening for the diagnosis and management of medullary thyroid carcinoma in multiple endocrine neoplasia type 2A.
    Vieira AE, Mello MP, Elias LL, Lau IF, Maciel LM, Moreira AC, Castro M.
    Horm Metab Res; 2002 Apr 05; 34(4):202-6. PubMed ID: 11987030
    [Abstract] [Full Text] [Related]

  • 13. Clinical characteristics and genetic screening of an extended family with MEN2A.
    Algün E, Abaci N, Kösem M, Kotan C, Köseoğlu B, Boztepe H, Sekeroğlu R, Aslan H, Topal C, Ayakta H, Uygan I, Alagöl F, Erginel-Unaltuna N, Aksoy H.
    J Endocrinol Invest; 2002 Apr 05; 25(7):603-8. PubMed ID: 12150334
    [Abstract] [Full Text] [Related]

  • 14. Treatment of minute medullary thyroid carcinoma in multiple endocrine neoplasia 2A families first diagnosed by DNA analysis of RET proto-oncogene mutations: a case report.
    Yamashita T, Lihara M, Okamoto J, Kanbe M, Ito Y, Kawakami M, Egawa S, Yamaguchi K, Obara T.
    Jpn J Clin Oncol; 1997 Feb 05; 27(1):42-5. PubMed ID: 9070340
    [Abstract] [Full Text] [Related]

  • 15. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
    Sanso GE, Domene HM, Garcia R, Pusiol E, de M, Roque M, Ring A, Perinetti H, Elsner B, Iorcansky S, Barontini M.
    Cancer; 2002 Jan 15; 94(2):323-30. PubMed ID: 11900218
    [Abstract] [Full Text] [Related]

  • 16. Pheochromocytoma as the first manifestation of MEN2A with RET mutation S891A: report of a case.
    Hibi Y, Ohye T, Ogawa K, Shimizu Y, Shibata M, Kagawa C, Mizuno Y, Uchino S, Kosugi S, Kurahashi H, Iwase K.
    Surg Today; 2014 Nov 15; 44(11):2195-200. PubMed ID: 24449023
    [Abstract] [Full Text] [Related]

  • 17. Multiple endocrine neoplasia type 2B.
    Nakata S, Okugi H, Saitoh Y, Takahashi H, Shimizu K.
    Int J Urol; 2001 Jul 15; 8(7):398-400. PubMed ID: 11442663
    [Abstract] [Full Text] [Related]

  • 18. Presentation of a kindred with familial medullary thyroid carcinoma and Cys611Phe mutation of the RET proto-oncogene demonstrating low grade malignancy.
    Siggelkow H, Melzer A, Nolte W, Karsten K, Hoppner W, Hufner M.
    Eur J Endocrinol; 2001 May 15; 144(5):467-73. PubMed ID: 11331212
    [Abstract] [Full Text] [Related]

  • 19. [Detection of RET-proto-oncogene mutations in the diagnosis of Type 2 endocrine neoplasia (MEN 2)].
    Komminoth P, Muletta-Feurer S, Soltermann A, Gemsenjäger E, Bürgi H, Staub JJ, Schönle E, Fried M, Vetter W, Spinas GA, Heitz PU.
    Schweiz Med Wochenschr; 1996 Aug 06; 126(31-32):1329-38. PubMed ID: 8765374
    [Abstract] [Full Text] [Related]

  • 20. Pheochromocytoma and medullary thyroid carcinoma: a new genotype-phenotype correlation of the RET protooncogene 891 germline mutation.
    Jimenez C, Habra MA, Huang SC, El-Naggar A, Shapiro SE, Evans DB, Cote G, Gagel RF.
    J Clin Endocrinol Metab; 2004 Aug 06; 89(8):4142-5. PubMed ID: 15292360
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.